MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sanchez, Noelia ^a   Gallagher, Mark ^a   Lao, Nga ^b   Gallagher, Clair ^a   Clarke, Colin ^a   Doolan, Padraig ^a   Aherne, Sinead ^a   Blanco, Alfonso ^b   Meleady, Paula ^a   Clynes, Martin ^a   Barron, Niall ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MICRORNA 7; NUCLEIC ACID BINDING PROTEIN; PROTEIN KINASE B; PROTEIN P53; PROTEIN RAD54L; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PSME3; TRANSCRIPTION FACTOR SKP3; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; AUTOANTIGEN; KI ANTIGEN; PROTEASOME; S PHASE KINASE ASSOCIATED PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PHASE TRANSITION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; CHO CELL LINE; CRICETULUS; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; AUTOANTIGENS; CHO CELLS; CRICETULUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878796457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065671     Document Type: Article

References (60)

1. Hu H, Gatti RA, (2011) MicroRNAs: New players in the DNA damage response. J Mol Cell Biol 3: 151-8.
2. Ichimura A, Ruike Y, Terasawa K, Tsujimoto G, (2011) miRNAs and regulation of cell signaling. FEBS J 278: 1610-8.
3. Cannell IG, Bushell M, (2010) Regulation of myc by miR-34c: A mechanism to prevent genomic instability? Cell Cycle 9: 2726-30.
4. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, et al. (2003) A uniform system for microRNA annotation. RNA 9: 277-9.
5. Lewis BP, Burge CB, Bartel DP, (2008) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
6. Müller D, Katinger H, Grillari J, (2008) MicroRNAs as targets for engineering of CHO cell factories. Trends Biotechnol 26: 359-65.
7. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD, (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123: 607-20.
8. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R, (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-40.
9. Pillai RS, (2005) MicroRNA function: Multiple mechanisms for a tiny RNA? RNA 11: 1753-61.
10. Doench JG, Petersen CP, Sharp PA, (2003) siRNAs can function as miRNAs. Genes Dev 17: 438-42.
11. Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27: 91-105.
12. McInnes N, Sadlon TJ, Brown CY, Pederson S, Beyer M, et al. (2011) FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 31: 1045-54.
13. Ikeda Y, Tanji E, Makino N, Kawata S, Furukawa T, (2012) MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer. Mol Cancer Res 10: 259-69.
14. Kefas B, Godlewski J, Comeau L, Li YQ, Abounader R, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-72.
15. Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, et al. (2010) EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70: 8822-31.
16. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, et al. (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432: 199-205.
17. Li X, Carthew RW, (2005) A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the drosophila eye. Cell 123: 1267-77.
18. Li X, Cassidy JJ, Reinke CA, Fischboeck S, Carthew RW, (2009) A MicroRNA imparts robustness against environmental fluctuation during development. Cell 137: 273-82.
19. Barron N, Kumar N, Sanchez N, Doolan P, Clarke C, et al. (2011) Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7. J Biotechnol 151: 204-11.
20. Ross HH, Levkoff LH, Marshall GP 2nd, Caldeira M, Steindler DA, et al. (2008) Bromodeoxyuridine induces senescence in neural stem and progenitor cells. Stem Cells 26: 3218-27.
21. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, et al. (2003) The F-box protein Skp2 participates in c-myc proteosomal degradation and acts as a cofactor for c-myc-regulated transcription. Mol Cell 11: 1189-200.
22. Zhang Z, Zhang R, (2008) Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J 27: 852-64.
23. Zhao X, Dou W, He L, Liang S, Tie J, et al. (2012) MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-72.
24. Shi W, Fan H, Shum L, Derynck R, (2000) The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 148: 591-602.
25. Haupt Y, Maya R, Kazaz A, Oren M, (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-9.
26. Kanaar R, Troelstra C, Swagemakers SM, Essers J, Smit B, et al. (1996) Human and mouse homologs of the saccharomyces cerevisiae RAD54 DNA repair gene: Evidence for functional conservation. Curr Biol 6: 828-38.
27. Heyer WD, Li X, Rolfsmeier M, Zhang XP, (2006) Rad54: The swiss army knife of homologous recombination? Nucleic Acids Res 34: 4115-25.
28. Fang Z, Rajewsky N, (2011) The impact of miRNA target sites in coding sequences and in 3′UTRs. PLoS One 6: e18067.
29. Rajewsky N, (2011) MicroRNAs and the operon paper. J Mol Biol 409: 70-5.
30. Meleady P, Gallagher M, Clarke C, Henry M, Sanchez N, et al. (2012) Impact of miR-7 over-expression on the proteome of chinese hamster ovary cells. J Biotechnol 160: 251-62.
31. Masson P, Lundgren J, Young P, (2003) Drosophila proteasome regulator REGgamma: Transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression. J Mol Biol 327: 1001-12.
32. Murata S, Kawahara H, Tohma S, Yamamoto K, Kasahara M, et al. (1999) Growth retardation in mice lacking the proteasome activator PA28gamma. J Biol Chem 274: 38211-5.
33. Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, et al. (2004) Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 18: 2602-7.
34. Zhang H, Kobayashi R, Galaktionov K, Beach D, (1995) p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82: 915-25.
35. Yu ZK, Gervais JL, Zhang H, (1998) Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A 95: 11324-9.
36. Brazil DP, Park J, Hemmings BA, (2002) PKB binding proteins, getting in on the akt. Cell 111: 293-303.
37. Diehl JA, Cheng M, Roussel MF, Sherr CJ, (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-511.
38. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, et al. (2012) The Skp2-SCF E3 ligase regulates akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149: 1098-111.
39. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, et al. (2009) Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 11: 420-32.
40. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP, (2003) Skp2 regulates myc protein stability and activity. Mol Cell 11: 1177-88.
41. Bretones G, Acosta JC, Caraballo JM, Ferrandiz N, Gomez-Casares MT, et al. (2011) SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J Biol Chem 286: 9815-25.
42. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, et al. (2009) miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3 ′ UTR MicroRNA recognition elements. Mol Cell 35: 610-25.
43. Challagundla KB, Sun XX, Zhang X, DeVine T, Zhang Q, et al. (2011) Ribosomal protein L11 recruits miR-24/miRISC to repress c-myc expression in response to ribosomal stress. Mol Cell Biol 31: 4007-21.
44. Mendez J, Zou-Yang XH, Kim SY, Hidaka M, Tansey WP, et al. (2002) Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol Cell 9: 481-91.
45. Li X, Zhao Q, Liao R, Sun P, Wu X, (2003) The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Biol Chem 278: 30854-8.
46. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S, (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
47. Vousden KH, Lu X, (2002) Live or let die: The cell's response to p53. Nat Rev Cancer 2: 594-604.
48. Vousden KH, Prives C, (2009) Blinded by the light: The growing complexity of p53. Cell 137: 413-31.
49. Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P, (2010) miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet 6: e1000795.
50. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, et al. (2001) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-18.
51. Kim AH, Sasaki T, Chao MV, (2003) JNK-interacting protein 1 promotes Akt1 activation. J Biol Chem 278: 29830-6.
52. Yamaguchi H, Wang HG, (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting bax conformational change. Oncogene 20: 7779-86.
53. Sarras H, Alizadeh Azami S, McPherson JP, (2010) In search of a function for BCLAF1. ScientificWorldJournal 10: 1450-61.
54. Kasof GM, Goyal L, White E, (1999) Btf, a novel death-promoting transcriptional repressor that interacts with bcl-2-related proteins. Mol Cell Biol 19: 4390-404.
55. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, et al. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21: 6236-45.
56. Brooks CL, Gu W, (2003) Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-71.
57. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W, (2008) Acetylation is indispensable for p53 activation. Cell 133: 612-26.
58. Ebert MS, Sharp PA, (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-24.
59. Clarke C, Doolan P, Barron N, Meleady P, O'Sullivan F, et al. (2011) Predicting cell-specific productivity from CHO gene expression. J Biotechnol 151: 159-65.
60. Wettenhall JM, Smyth GK, (2004) limmaGUI: A graphical user interface for linear modeling of microarray data. Bioinformatics 20: 3705-6.